FDA Inspection 1122292 — Northwestern Medicine Central DuPage Hospital
The FDA completed an inspection of Northwestern Medicine Central DuPage Hospital on Feb 4, 2020 in Winfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 4, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winfield, IL (United States)